{"id":130459,"date":"2021-11-12T08:22:37","date_gmt":"2021-11-12T16:22:37","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/11\/psilocybin-found-to-rapidly-improve-depressive-symptoms-in-patients-during-groundbreaking-clinical-trial"},"modified":"2021-11-12T08:22:37","modified_gmt":"2021-11-12T16:22:37","slug":"psilocybin-found-to-rapidly-improve-depressive-symptoms-in-patients-during-groundbreaking-clinical-trial","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/11\/psilocybin-found-to-rapidly-improve-depressive-symptoms-in-patients-during-groundbreaking-clinical-trial","title":{"rendered":"Psilocybin Found To Rapidly Improve Depressive Symptoms In Patients During \u2018Groundbreaking\u2019 Clinical Trial"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/psilocybin-found-to-rapidly-improve-depressive-symptoms-in-patients-during-groundbreaking-clinical-trial2.jpg\"><\/a><\/p>\n<p>\ud835\udc0f\ud835\udc2c\ud835\udc22\ud835\udc25\ud835\udc28\ud835\udc1c\ud835\udc32\ud835\udc1b\ud835\udc22\ud835\udc27 \ud835\udc05\ud835\udc28\ud835\udc2e\ud835\udc27\ud835\udc1d \ud835\udc13\ud835\udc28 \ud835\udc11\ud835\udc1a\ud835\udc29\ud835\udc22\ud835\udc1d\ud835\udc25\ud835\udc32 \ud835\udc08\ud835\udc26\ud835\udc29\ud835\udc2b\ud835\udc28\ud835\udc2f\ud835\udc1e \ud835\ude4d\ud835\ude56\ud835\ude65\ud835\ude5e\ud835\ude59\ud835\ude61\ud835\ude6e \ud835\ude44\ud835\ude62\ud835\ude65\ud835\ude67\ud835\ude64\ud835\ude6b\ud835\ude5a \ud835\ude3f\ud835\ude5a\ud835\ude65\ud835\ude67\ud835\ude5a\ud835\ude68\ud835\ude68\ud835\ude5e\ud835\ude6b\ud835\ude5a \ud835\ude4e\ud835\ude6e\ud835\ude62\ud835\ude65\ud835\ude69\ud835\ude64\ud835\ude62\ud835\ude68 \ud835\ude44\ud835\ude63 \ud835\ude4b\ud835\ude56\ud835\ude69\ud835\ude5e\ud835\ude5a\ud835\ude63\ud835\ude69\ud835\ude68 \ud835\ude3f\ud835\ude6a\ud835\ude67\ud835\ude5e\ud835\ude63\ud835\ude5c \u2018\ud835\ude42\ud835\ude67\ud835\ude64\ud835\ude6a\ud835\ude63\ud835\ude59\ud835\ude57\ud835\ude67\ud835\ude5a\ud835\ude56\ud835\ude60\ud835\ude5e\ud835\ude63\ud835\ude5c\u2019 \ud835\ude3e\ud835\ude61\ud835\ude5e\ud835\ude63\ud835\ude5e\ud835\ude58\ud835\ude56\ud835\ude61 \ud835\ude4f\ud835\ude67\ud835\ude5e\ud835\ude56\ud835\ude61<\/p>\n<p>\ud835\ude44\ud835\ude69 \ud835\ude69\ud835\ude6a\ud835\ude67\ud835\ude63\ud835\ude68 \ud835\ude64\ud835\ude6a\ud835\ude69 \ud835\ude69\ud835\ude5d\ud835\ude56\ud835\ude69 \ud835\ude5c\ud835\ude5e\ud835\ude6b\ud835\ude5e\ud835\ude63\ud835\ude5c \ud835\ude65\ud835\ude68\ud835\ude5e\ud835\ude61\ud835\ude64\ud835\ude58\ud835\ude6e\ud835\ude57\ud835\ude5e\ud835\ude63, \u2026 See more.<\/p>\n<hr>\n<p>Compass Pathways, a U.K. based clinical stage company that is developing a patented form of psilocybin to be used in conjunction with therapy, reported promising results from its much-anticipated phase two b clinical trial this week. <em> <\/em>The study found that patients who took a single psychedelic dose of psilocybin, 25 milligrams, in conjunction with therapy reported almost immediate and significant reduction in depressive symptoms that lasted weeks compared with patients who were given a 1 milligram dose, which is so low it\u2019s essentially a placebo.<\/p>\n<p>Twenty-nine patients, or 36.7%, who took the 25 mg dose showed a 50% or more reduction in symptoms in three weeks after the single dose and again at three months, compared with the patients who took the placebo. Nineteen patients, or 24.1%, who took the highest dose were still in remission three months later, compared with 17.7% after three weeks and 10.1% after three months in the 1 mg group.<\/p>\n<p>George Goldsmith, who cofounded Compass Pathways with his wife and medical doctor Ekaterina Malievskaia and Lars Christian Wilde, says that when they saw the positive results, they realized they were \u201cgroundbreaking.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ud835\udc0f\ud835\udc2c\ud835\udc22\ud835\udc25\ud835\udc28\ud835\udc1c\ud835\udc32\ud835\udc1b\ud835\udc22\ud835\udc27 \ud835\udc05\ud835\udc28\ud835\udc2e\ud835\udc27\ud835\udc1d \ud835\udc13\ud835\udc28 \ud835\udc11\ud835\udc1a\ud835\udc29\ud835\udc22\ud835\udc1d\ud835\udc25\ud835\udc32 \ud835\udc08\ud835\udc26\ud835\udc29\ud835\udc2b\ud835\udc28\ud835\udc2f\ud835\udc1e \ud835\ude4d\ud835\ude56\ud835\ude65\ud835\ude5e\ud835\ude59\ud835\ude61\ud835\ude6e \ud835\ude44\ud835\ude62\ud835\ude65\ud835\ude67\ud835\ude64\ud835\ude6b\ud835\ude5a \ud835\ude3f\ud835\ude5a\ud835\ude65\ud835\ude67\ud835\ude5a\ud835\ude68\ud835\ude68\ud835\ude5e\ud835\ude6b\ud835\ude5a \ud835\ude4e\ud835\ude6e\ud835\ude62\ud835\ude65\ud835\ude69\ud835\ude64\ud835\ude62\ud835\ude68 \ud835\ude44\ud835\ude63 \ud835\ude4b\ud835\ude56\ud835\ude69\ud835\ude5e\ud835\ude5a\ud835\ude63\ud835\ude69\ud835\ude68 \ud835\ude3f\ud835\ude6a\ud835\ude67\ud835\ude5e\ud835\ude63\ud835\ude5c \u2018\ud835\ude42\ud835\ude67\ud835\ude64\ud835\ude6a\ud835\ude63\ud835\ude59\ud835\ude57\ud835\ude67\ud835\ude5a\ud835\ude56\ud835\ude60\ud835\ude5e\ud835\ude63\ud835\ude5c\u2019 \ud835\ude3e\ud835\ude61\ud835\ude5e\ud835\ude63\ud835\ude5e\ud835\ude58\ud835\ude56\ud835\ude61 \ud835\ude4f\ud835\ude67\ud835\ude5e\ud835\ude56\ud835\ude61 \ud835\ude44\ud835\ude69 \ud835\ude69\ud835\ude6a\ud835\ude67\ud835\ude63\ud835\ude68 \ud835\ude64\ud835\ude6a\ud835\ude69 \ud835\ude69\ud835\ude5d\ud835\ude56\ud835\ude69 \ud835\ude5c\ud835\ude5e\ud835\ude6b\ud835\ude5e\ud835\ude63\ud835\ude5c \ud835\ude65\ud835\ude68\ud835\ude5e\ud835\ude61\ud835\ude64\ud835\ude58\ud835\ude6e\ud835\ude57\ud835\ude5e\ud835\ude63, \u2026 See more. Compass Pathways, a U.K. based clinical stage company that is developing a patented form of psilocybin to be used in conjunction with therapy, reported promising results from its much-anticipated phase two [\u2026]<\/p>\n","protected":false},"author":461,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-130459","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/130459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/461"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=130459"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/130459\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=130459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=130459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=130459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}